The partnership will commercialize four nasal sprays with a combined Global IQVIA market size in excess of $400m
Indoco expects this change in compliance status to pave the way for approvals of ANDAs submitted from this site.
It will help in bringing a significant benefit in compliance of ARV medication in the paediatric HIV treatment
Once approved, Columvi will be the first CD20xCD3 T-cell-engaging bispecific antibody available to treat people in Europe with this aggressive lymphoma
UAB Medexy's first order under the Distribution Agreement is for over 5000 units of SHIR and RELIEF&GO products
Super-Bond is made up of a polymerization initiator, a liquid and a polymer powder
The partnership will capitalize on the combined capabilities of the two organizations
Clinic will offer Comprehensive Genetic Counselling and Testing Services to empower patients with personalized care
The policymakers, doctors and, patient bodies discuss ways to implement thalassemia control programme nationally
Cipla has recently signed an agreement to make and market the diabetes therapy Galvus and its combination brands in India from 01 January 2026.
Subscribe To Our Newsletter & Stay Updated
